Insilico offers AI-based chemistry to coronavirus response

Insilico Medicine Inc. became the second AI company this week to contribute the speed of its platform to biopharma’s mass mobilization against the 2019-nCoV crisis.

As the debate continues about whether AI can transform medicinal chemistry versus just speed it up, outbreaks like the 2019-nCoV could be a proving ground for companies that believe their computational approaches can find compounds in a fraction of the time of traditional methods. ...